ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,563.18
      0.98%
      US Tech 100
      19,832.00
      0.97%
      Dow Jones
      39,321.20
      0.03%
      Brent Oil
      86.515
      -0.93%
      Bitcoin
      56,014.68
      -1.70%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Cellectis Nom Eo 05 (ALCLS) Quote

      Cellectis Nom Eo 05

      Cellectis Nom Eo 05 (ALCLS)

      EU
      1.832
      -0.012
      (-0.65%)
      Closed July 05 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.832
      Bid
      1.82
      Ask
      1.88
      Volume
      47,210
      1.82 Day's Range 1.88
      0.888 52 Week Range 3.44
      Market Cap
      84.593M
      Previous Close
      1.844
      Open
      1.88
      Last Trade
      54
      @
      1.832
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      104,066
      Shares Outstanding
      45,874,895
      Dividend Yield
      -
      PE Ratio
      -1.15
      Earnings Per Share (EPS)
      -2.2
      Revenue
      9.2M
      Net Profit
      -101.06M

      About Cellectis Nom Eo 05

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.cellectis.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1970
      Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 1.84 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 0.888 € to 3.44 €.

      Cellectis Nom Eo 05 currently has 45,874,895 shares outstanding. The market capitalization of Cellectis Nom Eo 05 is 84.59 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -1.15.

      ALCLS Latest News

      More News

      Résultats de l’Assemblée Générale Mixte de Cellectis du 28 juin 2024

      Résultats de l’Assemblée Générale Mixte de Cellectis du 28 juin 2024 NEW YORK, 28 juin 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de...

      June 28 2024
      GlobeNewswire Inc.

      Cellectis publie un article scientifique dévoilant trois facteurs clés pour une édition efficace avec des TALE base editors

      Cellectis publie un article scientifique dévoilant trois facteurs clés pour une édition efficace avec des TALE base editors NEW YORK, 20 juin 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext...

      June 20 2024
      GlobeNewswire Inc.

      Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

      NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ:  CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

      June 12 2024
      GlobeNewswire Inc.

      Monthly information on share capital and company voting rights

      Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority) PARIS, June 05, 2024 (GLOBE NEWSWIRE...

      June 05 2024
      GlobeNewswire Inc.

      Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

      Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS...

      June 05 2024
      GlobeNewswire Inc.

      Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia

      Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Cellectis...

      June 04 2024
      GlobeNewswire Inc.

      Cellectis obtient la désignation de médicament orphelin pour son produit CAR T allogénique UCART22 pour les patients atteints de leucémie lymphoblastique aiguë

      Cellectis obtient la désignation de médicament orphelin pour son produit CAR T allogénique UCART22 pour les patients atteints de leucémie lymphoblastique aiguë NEW YORK, 04 juin 2024 (GLOBE...

      June 04 2024
      GlobeNewswire Inc.

      L’ Assemblée Générale Mixte de Cellectis se tiendra le 28 juin 2024

      L’ Assemblée Générale Mixte de Cellectis se tiendra le 28 juin 2024 NEW YORK, 29 mai 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie...

      May 29 2024
      GlobeNewswire Inc.

      Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024

      NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...

      May 29 2024
      GlobeNewswire Inc.

      Cellectis publie ses résultats financiers du premier trimestre 2024

      Cellectis publie ses résultats financiers du premier trimestre 2024 •  Cellectis annonce la réalisation de l’investissement additionnel d’AstraZeneca •  Situation de trésorerie de 143...

      May 28 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.1589.438470728791.6741.8941.642648351.75768955DE
      4-0.513-21.87633262262.3452.381.6341103441.8788291DE
      12-0.788-30.07633587792.623.0251.6341040662.35560041DE
      26-0.848-31.64179104482.683.0251.6341011682.44376433DE
      520.0321.777777777781.83.440.8881791782.46437879DE
      156-10.918-85.63137254912.7513.220.8881677113.56295542DE
      260-11.868-86.627737226313.728.150.8881409986.92189318DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BENFBeneficient
      $ 4.81
      (123.72%)
      		35.19M
      QLGNQualigen Therapeutics Inc
      $ 0.2892
      (64.88%)
      		232.83M
      INVZWInnoviz Technologies Ltd
      $ 0.2499
      (51.91%)
      		17.79k
      SHOTWSafety Shot Inc
      $ 0.25
      (38.89%)
      		891
      MDWDMediWound Limited
      $ 20.1399
      (38.80%)
      		3.39M
      VEVVicinity Motor Corporation
      $ 0.3872
      (-31.35%)
      		303.6k
      SKYESkye Bioscience Inc
      $ 5.65
      (-24.26%)
      		214.08k
      SHPWShapeways Holdings Inc
      $ 0.21
      (-22.02%)
      		491.45k
      SPWRSunPower Corporation
      $ 2.095
      (-21.83%)
      		13.55M
      CYNCYNGN Inc
      $ 4.20
      (-21.79%)
      		290.71k
      MAXNMaxeon Solar Technologies Ltd
      $ 0.2302
      (32.60%)
      		325.05M
      QLGNQualigen Therapeutics Inc
      $ 0.2892
      (64.88%)
      		232.83M
      NVDANVIDIA Corporation
      $ 127.50
      (-0.61%)
      		146.02M
      TSLATesla Inc
      $ 247.765
      (0.56%)
      		111.47M
      SQQQProShares UltraPro Short QQQ
      $ 7.4501
      (-3.12%)
      		89.65M

      Discussion

      View Full Feed
      Humbert Humbert 3 minutes ago
      Can't imagine there are many more weak hands. The CEO's shares are restricted, so the sales are from older shareholders. For what's it's worth, I don't even want to touch my shares until this reaches .05 or so.
      BNCM
      paullina5555 paullina5555 3 minutes ago
      In other words to get them to sell so you can loader cheaper faster lol??
      SMCE
      RMS555 RMS555 3 minutes ago
      it looks like the fool force has taken a small vacation from posting on iHub.

      the fool force has met its match! (the fool force = VeronicaFox, Huggy Bear, DJ Ponder, and especially the kid THall)
      neomania neomania 3 minutes ago
      You guys wanted volume. You got it. This is heading south.
      NSAV
      Hoghead7 Hoghead7 3 minutes ago
      Short squeeze set up, c'mon 45V and another contract for $100M in S Korea
      https://www.google.com/url?rct=j&sa=t&url=https://www.marketbeat.com/instant-alerts/nasdaq-fcel-options-data-report-2024-07-03/&ct=ga&cd=CAEYACoTOTUyMDc4MzU2MDk1NDE3NTA4NTIaM2Y2YzEyOGYyMzM0YTgyODpjb206ZW46VVM&usg=AOvVa
      FCEL
      MightyX MightyX 4 minutes ago
      Based on yalls playbook..haha
      TPTW
      Patrick Bateman Patrick Bateman 4 minutes ago
      Again, if you read what I said, I am optimistic.

      I just don’t get why you thought there would be 100MM in volume suddenly.

      And, of course, I’m right.

      There isn’t.
      RITE
      HJ72 HJ72 4 minutes ago
      Yeah except rot in hell not RIP.
      MJLB
      LTListener LTListener 4 minutes ago
      I dont think those who choose to be in are looking to sell anytime soon. .02 is less than 20 million valuation and any BP/funding deal putting KRM-ll-81 into human trials will launch this into 100s of millions in value.

      This could be screaming at any moment, especially if FOMO kick
      RSPI
      The Night Stalker The Night Stalker 4 minutes ago
      a reassurance tweet of updates works lol
      ICTY
      peafunke peafunke 5 minutes ago
      It’s a troll. Either that or it’s a ai bot. You can see this by the types of replies. It’s a classic example.

      Don’t feed the pigeons.
      TPTW
      RMS555 RMS555 5 minutes ago
      this stock isn't ready for a moon blast, KE*S is though!!!!!
      XALL
      jimr1717 jimr1717 5 minutes ago
      “.0014’s” ouch the CONdog96 🤡©️ clown holds the bag once again

      Don’t get Conned by the one and only

      CONdog96 🤡©️ Clown



      CRSM
      Russ777 Russ777 5 minutes ago
      I believe they are setting themselves up for major success.
      BWVI
      Patrick Bateman Patrick Bateman 6 minutes ago
      What do you mean?

      Why do you say I have done no research? Cause I don’t know who’s on these boards? You realize IHUB is the worst board there is? I wouldn’t trust anything anyone says here…

      and btw, anyone who tells me the stock moved up when the last trade was on the
      CDBT
      JustDaTruthB JustDaTruthB 6 minutes ago
      5 day chart is trading at a sideway pattern,,, perhaps smooth sailing ahead???
      CYDY
      Chartmaster Chartmaster 6 minutes ago
      For my followers to know what I am doing
      SMCE
      arachnodude arachnodude 6 minutes ago
      Now, now, console yourself with your spreadsheet acumen. That should take your mind off things for some time. Unless, of course, you have an unlimited supply of tissues. Then by all means, keep crying. 😭😭😭😢🤣
      KBLB
      RMS555 RMS555 6 minutes ago
      didnt you say that last month when the pps was higher? LMFAO!

      Keep pumping CLOWN!!!!! Where is your buddy ORCA to spoof the bid? LMFAO!
      BLLB
      TOM611 TOM611 7 minutes ago
      Xall. Rockin and ready for the moon blast
      XALL
      paullina5555 paullina5555 7 minutes ago
      I know why you sold but why tell everyone that?
      SMCE
      glenn1919 glenn1919 7 minutes ago
      NEGG.....PSNY......BTBT........https://stockcharts.com/h-sc/ui?s=NEGG&p=W&b=5&g=0&id=p86431144783
      https://stockcharts.com/h-sc/ui?s=PSN&p=W&b=5&g=0&id=p86431144783
      https://stockcharts.com/h-sc/ui?s=BTBT&p=W&b=5&g=0&id=p86431144783
      BTBT NEGG PSNY
      infamous infamous 7 minutes ago
      even if they have 10 mil in revs, which i doubt, that wont translate to ANYTHING IMO with a 688mil OS. they would have to show a PROFIT of 6 mil to even sustain a .01 PPS
      ATWT
      Krspecialized Krspecialized 8 minutes ago
      Indeed, everything moving just the way it should.
      EMGE
      jimr1717 jimr1717 8 minutes ago
      Incorrect idiot. Time to place another bid at .00001!

      ROTFLMFAO
      CRSM

      Your Recent History

      EU
      ALCLS
      Cellectis Nom Eo 05
      NYSE
      LGI
      Lazard Global Total Retu...
      Delayed Upgrade Clock